Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-05 1:10 pm Purchase |
2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX |
Farallon Capital Partners, L.P. | 5,316,227 7.600% |
252,000![]() (+4.98%) |
Filing History |
2025-02-04 12:02 pm Purchase |
2024-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Farallon Capital Partners, L.P. | 5,674,466 9.900% |
13,600![]() (+0.24%) |
Filing History |
2024-11-14 8:21 pm Purchase |
2024-11-08 | 13G | Perspective Therapeutics, Inc. CATX |
Farallon Capital Partners, L.P. | 5,064,227 7.300% |
5,064,227![]() (New Position) |
Filing History |
2024-11-08 5:15 pm Purchase |
2024-09-30 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Farallon Capital Partners, L.P. | 3,456,063 9.990% |
1,250,073![]() (+56.67%) |
Filing History |
2024-11-08 2:57 pm Sale |
2024-09-30 | 13G | Aramark ARMK |
Farallon Capital Partners, L.P. | 11,636,937 4.400% |
-5,262,317![]() (-31.14%) |
Filing History |
2024-11-08 2:40 pm Purchase |
2024-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Farallon Capital Partners, L.P. | 5,660,866 9.900% |
1,493,264![]() (+35.83%) |
Filing History |
2024-11-08 11:54 am Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
Farallon Capital Partners, L.P. | 3,527,482 6.000% |
427,482![]() (+13.79%) |
Filing History |
2024-11-07 09:56 am Purchase |
2024-09-30 | 13G | Beam Therapeutics Inc. BEAM |
Farallon Capital Partners, L.P. | 8,208,123 9.900% |
4,102,370![]() (+99.92%) |
Filing History |
2024-11-06 6:32 pm Purchase |
2024-09-30 | 13G | Savara Inc. SVRA |
Farallon Capital Partners, L.P. | 17,762,533 9.990% |
3,435,622![]() (+23.98%) |
Filing History |
2024-11-06 5:06 pm Sale |
2024-09-30 | 13G | Swiftmerge Acquisition Corp. IVCP |
Farallon Capital Partners, L.P. | 471,366 9.900% |
-53,634![]() (-10.22%) |
Filing History |
2024-10-16 4:35 pm Purchase |
2024-10-09 | 13D | Squarespace, Inc. SQSP |
Farallon Capital Partners, L.P. | 5,600,000 6.100% |
5,600,000![]() (New Position) |
Filing History |
2024-05-17 4:58 pm Purchase |
2024-05-09 | 13G | NanoString Technologies, Inc. NSTGQ |
Farallon Capital Partners, L.P. | 4,391,941 9.100% |
4,391,941![]() (New Position) |
Filing History |
2024-05-08 4:11 pm Purchase |
2024-05-06 | 13D | Exelixis, Inc. EXEL |
Farallon Capital Partners, L.P. | 26,769,500 9.200% |
909,500![]() (+3.52%) |
Filing History |
2024-02-14 09:33 am Purchase |
2023-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Farallon Capital Partners, L.P. | 151,740 9.900% |
234![]() (+0.15%) |
Filing History |
2024-02-12 5:11 pm Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 6,750,204 4.100% |
-12,276![]() (-0.18%) |
Filing History |
2024-02-12 3:38 pm Sale |
2023-12-31 | 13G | Beam Therapeutics Inc. BEAM |
Farallon Capital Partners, L.P. | 4,105,753 5.000% |
-7,716![]() (-0.19%) |
Filing History |
2024-02-08 11:39 am Purchase |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Farallon Capital Partners, L.P. | 4,167,602 7.500% |
206,000![]() (+5.20%) |
Filing History |
2024-02-06 10:16 am Purchase |
2023-12-31 | 13G | Aramark ARMK |
Farallon Capital Partners, L.P. | 16,899,254 6.400% |
1,518,185![]() (+9.87%) |
Filing History |
2024-02-05 5:28 pm Unchanged |
2024-02-01 | 13D | Cazoo Group Ltd CZOOF |
Farallon Capital Partners, L.P. | 7,142 14.600% |
0 (Unchanged) |
Filing History |
2024-02-05 11:22 am Sale |
2023-12-31 | 13G | Swiftmerge Acquisition Corp. IVCP |
Farallon Capital Partners, L.P. | 525,000 9.000% |
-1,680,000![]() (-76.19%) |
Filing History |